Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
08:37:48 EDT Sun 20 Apr 2025
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

News for C:MDP from 2024-04-19 to 2025-04-18 - 55 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2025-04-17 16:34C:MDPMedexus Pharmaceuticals Inc2.55News ReleaseMedexus completes listing agreement for Trecondyv
2025-04-07 16:19C:MDPMedexus Pharmaceuticals Inc2.17News ReleaseMedexus talks up market response to Grafapex
2025-03-14 14:15C:MDPMedexus Pharmaceuticals Inc2.57News ReleaseMedexus completes cancellation of Gleolan U.S. licence
2025-02-24 16:32C:MDPMedexus Pharmaceuticals Inc2.98News ReleaseMedexus's Grafapex for injection available in U.S.
2025-02-07 05:42C:MDPMedexus Pharmaceuticals Inc3.21In the NewsGlobe says Medexus Pharmaceuticals lowered to "hold"
2025-02-06 10:51C:MDPMEDEXUS PHARMACEUTICALS INC. J3.79News ReleaseCanadian Investment Regulatory Organization Trade Resumption - MDP
2025-02-06 10:45C:MDPMEDEXUS PHARMACEUTICALS INC. J3.79News ReleaseCanadian Investment Regulatory Organization Trading Halt - MDP
2025-02-06 10:35C:MDPMedexus Pharmaceuticals Inc3.79Resume TradingMedexus Pharmaceuticals to resume at 7:36 a.m. PT
2025-02-06 10:34C:MDPMedexus Pharmaceuticals Inc3.79Halt TradingMedexus Pharmaceuticals halted at 7:31 a.m. PT
2025-02-05 17:39C:MDPMedexus Pharmaceuticals Inc3.79SEDAR Interim MD & ASEDAR Interim MD & A
2025-02-05 17:38C:MDPMedexus Pharmaceuticals Inc3.79SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-02-05 17:31C:MDPMEDEXUS PHARMACEUTICALS INC. J3.79News ReleaseMedexus Announces Strong Fiscal Q3 2025 Results, Well-Positioned to Launch GRAFAPEX (treosulfan) for Injection in the United States
2025-02-04 17:54C:MDPMedexus Pharmaceuticals Inc3.87News ReleaseMedexus completes listing agreements with Ontario
2025-01-31 18:21C:MDPMedexus Pharmaceuticals Inc3.85News ReleaseMedexus to release fiscal Q3 results Feb. 5
2025-01-31 16:44C:MDPMedexus Pharmaceuticals Inc3.85News ReleaseMedexus Pharmaceuticals closes $30-million offering
2025-01-29 20:27C:MDPMedexus Pharmaceuticals Inc4.00Prospectus ApprovedMedexus Pharmaceuticals to list 7.5 million more shares
2025-01-28 10:00C:MDPMedexus Pharmaceuticals Inc4.60News ReleaseMedexus Pharmaceuticals prices $30M overnight offering
2025-01-28 09:47C:MDPMEDEXUS PHARMACEUTICALS INC. J4.60News ReleaseCanadian Investment Regulatory Organization Trade Resumption - MDP
2025-01-28 09:36C:MDPMedexus Pharmaceuticals Inc4.60Resume TradingMedexus Pharmaceuticals to resume at 7 a.m. PT
2025-01-27 16:11C:MDPMedexus Pharmaceuticals Inc4.60News ReleaseMedexus arranges overnight public offering of shares
2025-01-27 15:44C:MDPMEDEXUS PHARMACEUTICALS INC. J4.92News ReleaseCanadian Investment Regulatory Organization Trading Halt - MDP
2025-01-27 15:44C:MDPMedexus Pharmaceuticals Inc4.92Halt TradingMedexus Pharmaceuticals halted at 12:33 p.m. PT
2025-01-22 18:33C:MDPMedexus Pharmaceuticals Inc4.75News ReleaseMedexus receives FDA approval for Grafapex
2025-01-22 11:17C:MDPMEDEXUS PHARMACEUTICALS INC. J3.99News ReleaseCanadian Investment Regulatory Organization Trade Resumption - MDP
2025-01-22 11:04C:MDPMedexus Pharmaceuticals Inc3.99Resume TradingMedexus Pharmaceuticals to resume at 8:30 a.m. PT
2025-01-22 10:13C:MDPMEDEXUS PHARMACEUTICALS INC. J3.99News ReleaseCanadian Investment Regulatory Organization Trading Halt - MDP
2025-01-22 10:05C:MDPMedexus Pharmaceuticals Inc3.99Halt TradingMedexus Pharmaceuticals halted at 7:01 a.m. PT
2025-01-15 16:40C:MDPMedexus Pharmaceuticals Inc4.33News ReleaseMedexus completes B.C. listing agreement for treosulfan
2025-01-09 07:16C:MDPMedexus Pharmaceuticals Inc3.60In the NewsGlobe says Medexus upgraded to "strong buy"
2024-12-02 17:51C:MDPMedexus Pharmaceuticals Inc2.82News ReleaseMedexus amends U.S. treosulfan licence with Medac
2024-11-18 14:27C:MDPMedexus Pharmaceuticals Inc2.12News ReleaseMedexus completes Trecondyv negotiation with pCPA
2024-11-08 15:38C:MDPMedexus Pharmaceuticals Inc2.17SEDAR Final Short Form ProspectusSEDAR Final Short Form Prospectus
2024-11-08 12:14C:MDPMedexus Pharmaceuticals Inc2.20SEDAR Preliminary Short Form ProspectusSEDAR Preliminary Short Form Prospectus
2024-11-07 17:59C:MDPMedexus Pharmaceuticals Inc2.20SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-11-07 17:59C:MDPMedexus Pharmaceuticals Inc2.20SEDAR Interim MD & ASEDAR Interim MD & A
2024-11-07 17:31C:MDPMEDEXUS PHARMACEUTICALS INC. J2.20News ReleaseMedexus Announces Strong Fiscal Q2 2025 Results
2024-10-29 17:59C:MDPMedexus Pharmaceuticals Inc2.58News ReleaseMedexus to release fiscal Q2 results Nov. 7
2024-10-01 08:30C:MDPMedexus Pharmaceuticals Inc2.65In the NewsGlobe says new coverage rates Medexus "speculative buy"
2024-09-19 17:37C:MDPMedexus Pharmaceuticals Inc2.50News ReleaseMedexus Pharmaceuticals holders approve AGM resolutions
2024-09-16 15:31C:MDPMedexus Pharmaceuticals Inc2.33News ReleaseMedexus's Treosulfan NDA review extended by FDA
2024-08-23 06:57C:MDPMedexus Pharmaceuticals Inc2.41In the NewsGlobe says Medexus Pharmaceuticals maintained at "buy"
2024-08-14 09:02C:MDPMedexus Pharmaceuticals Inc2.49In the NewsGlobe says Treosulfan could double Medexus's sales
2024-08-07 18:51C:MDPMedexus Pharmaceuticals Inc2.27SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-08-07 18:51C:MDPMedexus Pharmaceuticals Inc2.27SEDAR Interim MD & ASEDAR Interim MD & A
2024-08-07 17:43C:MDPMEDEXUS PHARMACEUTICALS INC. J2.27News ReleaseMedexus Announces Strong Fiscal Q1 2025 Results
2024-07-30 17:48C:MDPMedexus Pharmaceuticals Inc2.34News ReleaseMedexus Pharmaceuticals to release Q1 results Aug. 7
2024-06-25 19:06C:MDPMedexus Pharmaceuticals Inc1.69SEDAR Annual Information FormSEDAR Annual Information Form
2024-06-25 18:56C:MDPMedexus Pharmaceuticals Inc1.69News ReleaseMedexus loses $200,000 (U.S.) in fiscal 2024
2024-06-25 18:49C:MDPMedexus Pharmaceuticals Inc1.69SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-06-25 18:49C:MDPMedexus Pharmaceuticals Inc1.69SEDAR MD & ASEDAR MD & A
2024-06-18 17:15C:MDPMedexus Pharmaceuticals Inc1.63News ReleaseMedexus to release fiscal 2024 results June 25
2024-06-06 10:35C:MDPMedexus Pharmaceuticals Inc1.62News ReleaseMedexus's treosulfan NDA resubmission accepted by FDA
2024-06-06 10:26C:MDPMedexus Pharmaceuticals Inc1.62Resume TradingMedexus Pharmaceuticals to resume at 8 a.m. PT
2024-06-06 10:05C:MDPMedexus Pharmaceuticals Inc1.62Halt TradingMedexus Pharmaceuticals halted at 7:04 a.m. PT
2024-05-01 17:47C:MDPMedexus Pharmaceuticals Inc1.75News ReleaseMedexus's Metoject patent no longer in effect in Canada